K C Bible1, R H Bible, T J Kottke
1Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Flavopiridol, a cyclin-dependent kinase inhibitor, shows cytotoxic effects on noncycling cells. Studies suggest flavopiridol also binds to DNA, potentially acting as a second target and explaining its efficacy against cancer cells.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: